Skip Navigation
The global source of news, directories, proprietary market research, and analysis for clinical trials professionals and patients
Search
Home » Advanced Search
Search Results for Serotonin Reuptake Inhibitors
Perform Another (Advanced) Search
33 Results within Entire Site
Limit results to show: Entire Site Clinical Trial Listings Newly Approved Drugs Research Center Profiles Industry Providers New Medical Results Clinical Trials Today Headlines
Displaying results 1—20
Next > Last »
1. Study Posting (2348) Trial #50072, Obsessive-Compulsive Disorders, New York, NY ...Posting (2348) Trial #50072, Obsessive-Compulsive Disorders, New York, NY Trial Information Ziprasidone augmentation in serotonin reuptake inhibitor-resistant Obsessive-Compulsive Disorder The purpose of this study is to determine whether the ...View Page
2. Study Posting (799) Trial #161750, Depression, Boston, MA ...Study Posting (799) Trial #161750, Depression, Boston, MA combination of Ziprasidone with the selective serotonin reuptake inhibitor (SSRI)<br/>Escitalopram for patients with Major Depressive Disorder (MDD) that do not sufficiently ...View Page
3. Study Posting (799) Trial #159744, Depression, Boston, MA ...Study Posting (799) Trial #159744, Depression, Boston, MA combination of Ziprasidone with the selective serotonin reuptake inhibitor (SSRI)<br/>Escitalopram for patients with Major Depressive Disorder (MDD) that do not sufficiently ...View Page
4. Study Posting (799) Trial #156617, Depression, Boston, MA ...Study Posting (799) Trial #156617, Depression, Boston, MA combination of Ziprasidone with the selective serotonin reuptake inhibitor (SSRI)<br/>Escitalopram for patients with Major Depressive Disorder (MDD) that do not sufficiently ...View Page
5. Study Posting (799) Trial #161751, Depression (Treatment-Resistant), Boston, MA ...Posting (799) Trial #161751, Depression (Treatment-Resistant), Boston, MA combination of Ziprasidone with the selective serotonin reuptake inhibitor (SSRI)<br/>Escitalopram for patients with Major Depressive Disorder (MDD) that do not sufficiently ...View Page
6. Study Posting (799) Trial #161733, Depression (Major/Severe), Boston, MA ...Posting (799) Trial #161733, Depression (Major/Severe), Boston, MA combination of Ziprasidone with the selective serotonin reuptake inhibitor (SSRI)<br/>Escitalopram for patients with Major Depressive Disorder (MDD) that do not sufficiently ...View Page
7. Study Posting (799) Trial #159734, Depression (Major/Severe), Boston, MA ...Posting (799) Trial #159734, Depression (Major/Severe), Boston, MA combination of Ziprasidone with the selective serotonin reuptake inhibitor (SSRI)<br/>Escitalopram for patients with Major Depressive Disorder (MDD) that do not sufficiently ...View Page
8. Study Posting (799) Trial #156606, *Healthy Patient Studies, Boston, MA ...Posting (799) Trial #156606, *Healthy Patient Studies, Boston, MA combination of Ziprasidone with the selective serotonin reuptake inhibitor (SSRI)<br/>Escitalopram for patients with Major Depressive Disorder (MDD) that do not sufficiently ...View Page
9. Study Posting (2348) Trial #53934, Body Dysmorphic Disorder, New York, NY ...Body Dysmorphic Disorder, New York, NY Trial Information Cognitive-Behavioral Therapy as an Adjunct to Serotonin Reuptake Inhibitors in the Treatment of Body Dysmorphic Disorder The purpose of this study is to ...View Page
10. Study Posting (709) Trial #116328, Depression, Stanford, CA ...is to get information on the effectiveness of switching to duloxetine (Cymbalta) from a selective serotonin reuptake inhibitor (SSRI) to relieve sexual dysfunction in patients with depression. Duloxetine has been approved by ...View Page
11. Study Posting (709) Trial #116327, Sexual Dysfunction, Stanford, CA ...is to get information on the effectiveness of switching to duloxetine (Cymbalta) from a selective serotonin reuptake inhibitor (SSRI) to relieve sexual dysfunction in patients with depression. Duloxetine has been approved by ...View Page
12. Newly Approved Drug Therapies (796) Lexapro (escitalopram oxalate), Forest Laboratories, ...recommended dose of Lexapro is 10 mg daily. Lexapro (escitalopram oxalate), an orally administered selective serotonin reuptake inhibitor (SSI), is indicated for the treatment of major depressive disorder. Lexapro is the single ...View Page
13. CenterWatch: Clinical Trials in Category (46) Depression (Treatment-Resistant) ...to test the efficacy, tolerability and safety of the combination of Ziprasidone with the selective serotonin reuptake inhibitor (SSRI) Escitalopram for patients with Major Depressive Disorder (MDD) that do not sufficiently respond ...View Page
14. Study Posting (2829) Trial #155112, Depression, San Antonio, TX ...who were identified as partial responders to an adequate course of treatment with a selective serotonin reuptake inhibitor (SSRI) (as defined by history). Inclusion Criteria: • Meet criteria for MDD as defined by ...View Page
15. Newly Approved Drug Therapies (104) Paxil (paroxetine hydrochloride), SmithKline Beecham, ...some time in their lives. Paxil belongs to a class of antidepressants known as selective serotonin reuptake inhibitors (SSRIs). For many years, the only drug indicated for panic disorder was the benzodiazepine ...View Page
16. CenterWatch: Clinical Trials in Category (642) Body Dysmorphic Disorder ...New York New York : Mount Sinai Medical Center Cognitive-Behavioral Therapy as an Adjunct to Serotonin Reuptake Inhibitors in the Treatment of Body Dysmorphic Disorder Jobson Medical Information • Privacy | • Glossary Copyright © 1995 ...View Page
17. Newly Approved Drug Therapies (685) Prozac Weekly (fluoxetine HCl), Eli Lilly, ...an enteric coating that delays release into the bloodstream. Fluoxetine is known as a selective serotonin reuptake inhibitor - it is believed to provide a therapeutic effect by blocking neuronal (nerve cell) uptake ...View Page
18. CenterWatch: Clinical Trials in Category (108) Obsessive-Compulsive Disorders ...York Chronic Obstructive Pulmonary Disease- Adults New York : Mount Sinai Medical Center Ziprasidone augmentation in serotonin reuptake inhibitor-resistant Obsessive-Compulsive Disorder Jobson Medical Information • Privacy | • Glossary Copyright © 1995-2010 Jobson Medical ...View Page
19. CenterWatch: Psychiatry/Psychology Approved Drug Therapies ...in schizophrenia patients, Approved June 2002 Lexapro (escitalopram oxalate) ; Forest Laboratories; An orally administered selective serotonin reuptake inhibitor useful for the treatment for major depressive disorder, Approved August 2002 Paxil CR (paroxetine ...View Page
20. Study Posting (1918) Trial #159850, Prostate Cancer, Savannah, GA ...See Disease Characteristics • More than 14 days since prior venlafaxine, monoamine oxidase inhibitor (MAOI), selective serotonin reuptake inhibitor (SSRI), or selective norepinephrine reuptake inhibitor (SNRI) • No concurrent chemotherapy, radiotherapy, or surgery • No ...View Page
Copyright © 2008 Jobson Medical Information LLC.
Designed by Piehead Productions LLC.